Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II

NCT06882499 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer, Metastatic
Metastatic Breast Cancer

Interventions

RADIATION: Stereotactic Ablative Radiotherapy
OTHER: Physician's choice of systemic treatment

Sponsor

Peter MacCallum Cancer Centre, Australia